Over the past few years, courts in Delaware and Canada,
and Canadian securities regulators, have grappled with approaches
to disputes over deal terms, including in recent litigation arising
in the context of the COVID-19 pandemic. While different
conclusions may be reached on the particular facts of a
transaction, Canadian and Delaware deal principles are developing
along similar lines in a number of key areas.
In this article, we address recent developments in the
jurisprudence around material adverse effect (MAE) clauses,
appraisal rights and the board and shareholder processes
appropriate for conflicted transactions.
The interpretation of MAE clauses: challenges for buyers on
both sides of the border